We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-4.36%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$51.2M
(+29%)
Cap. Flow
+$59.1M
Cap. Flow
% of AUM
25.9%
Top 10 Holdings %
Top 10 Hldgs %
8.62%
Holding
1,075
New
434
Increased
121
Reduced
77
Closed
439
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.63M |
| 2 |
UnitedHealth
UNH
|
+$2.03M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.69M |
| 4 |
Procter & Gamble
PG
|
+$1.68M |
| 5 |
Yum! Brands
YUM
|
+$1.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.15M |
| 2 |
NVIDIA
NVDA
|
+$3.11M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.76M |
| 4 |
Boeing
BA
|
+$1.89M |
| 5 |
Micron Technology
MU
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.16% |
| 2 | Healthcare | 19.01% |
| 3 | Financials | 12.5% |
| 4 | Consumer Discretionary | 11.47% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
NovoCure
NVCR
$2.04B
| – | – |
-3,172
| Closed | -$238K |
|
|
NVO
877
Novo Nordisk
NVO
$216B
| – | – |
-4,792
| Closed | -$268K |
|
878
NVR
NVR
$17.2B
| – | – |
-58
| Closed | -$343K |
|
879
Novartis
NVS
$295B
| – | – |
-5,972
| Closed | -$522K |
|
880
Ocugen
OCGN
$410M
| – | – |
-13,893
| Closed | -$63K |
|
881
ONE Gas
OGS
$5.05B
| – | – |
-3,143
| Closed | -$244K |
|
|
OLPX
882
DELISTED
Olaplex Holdings
OLPX
| – | – |
-8,948
| Closed | -$261K |
|
|
ACH
883
Accendra Health
ACH
$240M
| – | – |
-7,175
| Closed | -$312K |
|
884
Offerpad Solutions
OPAD
$19M
| – | – |
-131
| Closed | -$126K |
|
885
OptimizeRx
OPRX
$117M
| – | – |
-4,562
| Closed | -$283K |
|
886
Oracle
ORCL
$331B
| – | – |
-11,050
| Closed | -$964K |
|
887
Oramed Pharmaceuticals
ORMP
$165M
| – | – |
-10,556
| Closed | -$151K |
|
888
Otis Worldwide
OTIS
$27.4B
| – | – |
-4,544
| Closed | -$396K |
|
889
Ouster
OUST
$2.29B
| – | – |
-1,209
| Closed | -$63K |
|
890
Pitney Bowes
PBI
$2.42B
| – | – |
-20,270
| Closed | -$134K |
|
891
Petrobras
PBR
$121B
| – | – |
-12,464
| Closed | -$137K |
|
|
892
Petrobras Class A
PBR.A
$107B
| – | – |
-20,290
| Closed | -$205K |
|
893
Pegasystems
PEGA
$4.41B
| – | – |
-5,192
| Closed | -$290K |
|
894
PepsiCo
PEP
$186B
| – | – |
-2,593
| Closed | -$450K |
|
895
Pfizer
PFE
$140B
| – | – |
-4,602
| Closed | -$272K |
|
896
PennyMac Financial
PFSI
$4.38B
| – | – |
-4,085
| Closed | -$285K |
|
897
Polaris
PII
$4.15B
| – | – |
-2,915
| Closed | -$320K |
|
898
Planet Labs
PL
$7.3B
| – | – |
-18,959
| Closed | -$117K |
|
899
Polar Power
POLA
$5.28M
| – | – |
-1,433
| Closed | -$36K |
|
900
Post Holdings
POST
$4.12B
| – | – |
-4,674
| Closed | -$345K |
|
Similar funds
HW
AAM
RWM
SAM
FWI
PP
VH
TSW
XTX Topco's Q1 2022 Portfolio in Review
As of Q1 2022, XTX Topco held 1,075 positions worth $228M, up 29% from $177M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
XTX Topco deployed $59.1M of net new capital in Q1 2022, opening 434 new positions and adding to 121 existing holdings. Its largest new stake was UnitedHealth: 4,214 shares worth $2.15M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $3.11M trimmed.
- XTX Topco's largest Q1 2022 buy was UnitedHealth: 4,214 shares worth $2.15M.
- XTX Topco added most to Johnson & Johnson in Q1 2022, an estimated $2.63M increase.
- XTX Topco's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $3.11M.
- XTX Topco fully exited Microsoft in Q1 2022, selling an estimated $3.15M.
- XTX Topco's ten largest holdings make up 8.6% of its $228M portfolio in Q1 2022.
- XTX Topco opened 434 new positions and closed 439 in Q1 2022.
- XTX Topco's portfolio value rose 29% quarter-over-quarter to $228M.
Based on XTX Topco's 13F filing for Q1 2022, filed 13 May 2022.